Full-Dose Heparin May Aid Moderately Ill COVID-19 Patients
MONDAY, Jan. 25, 2021 -- Evidence suggests that full-dose anticoagulation treatment reduces the need for vital organ support such as ventilation and may reduce mortality in moderately ill patients hospitalized with COVID-19, according to interim results of research funded by the National Health, Lung, and Blood Institute.
Researchers conducted three clinical trials in more than 300 hospitals across five continents to examine the potential benefit of full doses versus lower doses of heparin to treat moderately ill hospitalized adults with COVID-19.
Based on the interim results from more than 1,000 patients, full doses of heparin were found to be safe and were superior to doses normally given to prevent blood clots in hospitalized patients with respect to the primary end point of need for ventilation or other organ-supportive interventions. The full results will be made available as soon as possible to aid clinicians in making informed decisions about patient care.
"The trial results reported today complement the group's findings announced in December that routine use of full-dose anticoagulation when started in the intensive care unit in critically ill COVID-19 patients was not beneficial and may have been harmful in some patients," according to the press release.
© 2021 HealthDay. All rights reserved.
Posted: January 2021
Further Support and Information on COVID-19
Read this next
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of March 1 to 5, 2021. This roundup...
FRIDAY, March 5, 2021 -- Countries worldwide are struggling to find enough syringes to administer COVID-19 vaccines. Experts say between 8 billion and 10 billion syringes are...
FRIDAY, March 5, 2021 -- Two cases of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant P.1 identified in Minnesota are described in a report published in...
More News Resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our Newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.